4//SEC Filing
DeSilva Nishan M 4
Accession 0001453687-25-000015
CIK 0001453687other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:19 PM ET
Size
8.6 KB
Accession
0001453687-25-000015
Insider Transaction Report
Form 4
DeSilva Nishan M
Director
Transactions
- Award
Common Stock
2025-01-02+2,600→ 8,766 total - Award
Stock Option (Right to Buy)
2025-01-02+7,800→ 7,800 totalExercise: $16.93From: 2026-01-02Exp: 2035-01-01→ Common Stock (7,800 underlying)
Holdings
- 7,600
Stock Option (Right to Buy)
Exercise: $19.66Exp: 2034-01-01→ Common Stock (7,600 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.
- [F2]On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F3]This award vests in 36 equal monthly installments following the date of grant, so that it shall be fully vested on January 2, 2027.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001492386
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:19 PM ET
- Size
- 8.6 KB